CL monthly performance report
Monthly CL research: returns, drawdown, relative strength, seasonality, and key stats.
CL monthly report
—
Key takeaways
- Colgate-Palmolive (CL) closed August 2026 at $93.28, up 2.17% for the month and +12.30% over the trailing 12 months.
- Year-to-date, CL is +18.05%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +8.12% versus its 200-day moving average ($86.28), a bullish technical signal.
- Over the past three years, CL has underperformed the S&P 500 by −49.97%, with a relative strength index reading of 71.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Colgate-Palmolive ended August 2026 at $93.28, posting a monthly return of +2.17%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −0.88%.
The current quarter stands at +4.11% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +8.12% versus the 200-day moving average ($86.28).
Year-to-date, CL is +18.05% against SPY +12.89%, a gap of +5.16%. The stock is currently −6.09% below its 52-week high, with maximum 3-year drawdown at −31.07%.
| Period | CL | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.81% | −0.20% | +1.01% |
| 1 Week | +0.59% | +3.90% | −3.31% |
| 1 Month | +2.17% | +3.05% | −0.88% |
| 3 Months | +9.28% | +7.11% | +2.16% |
| 6 Months |